David Holmes | executive |
Michael Egholm | executive |
Jeffrey Black | executive |
Matthew Stanton | analyst |
Daniel Brennan | analyst |
Paul Knight | analyst |
Good day, and welcome to the Standard BioTools Second Quarter 2024 Earnings Conference Call. [Operator Instructions]. Please note, this event is being recorded.
I would now like to turn the conference over to David Holmes of Investor Relations.